成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
上海一飛生物科技有限公司 公司信息
公司名稱:
上海一飛生物科技有限公司
電話:
021-65675885
電子郵件:
customer_service@efebio.com
國(guó)籍:
中國(guó)
網(wǎng)址:
http://www.efebio.com
產(chǎn)品總數(shù):
11974
112
113
114
115
116
117
118
119
120
公司提供產(chǎn)品列表
Thalidomide-4-NH-PEG1-NH2 TFA
1H-ISOINDOLE-1,3(2H)-DIONE, 4-[[2-(2-AMINOETHOXY)ETHYL]AMINO]-2-(2,6-DIOXO-3-PIPERIDINYL)-, 2,2,2-TR
2490499-21-1
Thalidomide-4-NH-PEG1-NH-Boc
沙利度胺-NH-PEG1-NH-BOC
2154342-17-1
JYS003
L-PROLINAMIDE, N-[4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-OXOBUTYL]-3-METHYL-L-VALYL-4-HYDROXY-N-[
2361119-87-9
Ergosinine
異麥角生鹼
596-88-3
Erlizumab
厄利珠單抗
211323-03-4
2,6-Diethylnaphthalene
2,6-二乙基萘
59919-41-4
Thalidomide-NH-(CH2)2-NH-Boc
沙利度胺-NH-C2-NH-Boc
1957235-57-2
Roledumab
ROLEDUMAB ( 羅來度單抗 )
1174008-79-7
Bimagrumab
Bimagrumab
1356922-05-8
Vandortuzumab
Vandortuzumab Vedotin
1471985-92-8
Dezamizumab
Dezamizumab
1662664-56-3
Ieramilimab
埃拉利單抗
2137049-37-5
2,3,4-Trichlorophenol acetate
2,3,4-三氯苯酚乙酸酯
61925-89-1
Capromab
CAPROMAB
145464-28-4
Derlotuximab
Cotara (9CI)
340013-96-9
Clothianidin-urea
Urea, N-[(2-chloro-5-thiazolyl)methyl]-N'-methyl-
634192-72-6
Landogrozumab
Landogrozumab
1391726-30-9
Vadastuximab
Vadastuximab
1436390-63-4
Ivuxolimab
IVUXOLIMAB (艾沃利單抗 )
2225940-98-5
Altumomab
阿妥莫單抗
156586-92-4
3,4,5-Trichlorophenol acetate
3,4,5-三氯苯酚乙酸酯
59190-61-3
Indatuximab
Indatuximab Ravtansine
1238517-16-2
JYS007
L-PROLINAMIDE, N-(12,12-DIMETHYL-1,10-DIOXO-3,6,11-TRIOXA-9-AZATRIDEC-1-YL)-3-METHYL-L-VALYL-4-HYDRO
2162120-75-2
Nofetumomab
Merpentan
165942-79-0
JYS005
L-PROLINAMIDE, N-[8-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-OXOOCTYL]-3-METHYL-L-VALYL-4-HYDROXY-N-[
2306389-02-4
JYS006
L-PROLINAMIDE, N-[2-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHOXY]ACETYL]-3-METHYL-L-VALYL-4-HYDROX
2409007-41-4
Ecromeximab
Kw-2871
292819-64-8
5,10,15,20-Tetraoxatetracosane-1,24-diol
5,10,15,20-四氧辛酸酯-1,24-二醇
61136-08-1
Oportuzumab
Oportuzumab Monatox
945228-48-8
Denintuzumab
Denintuzumab Mafodotin
1399672-02-6
Olendalizumab
Olendalizumab
1337966-73-0
Balstilimab
BALSTILIMAB (巴替利單抗 )
2230167-06-1
Thalidomide-NH-CH2-COO(t-Bu)
沙利度胺-NH-C2-NH-COO(T-BU)
2093386-23-1
Stamulumab
司他莫魯
705287-60-1
Imciromab
英西單抗
126132-83-0
Zolimomab
阿佐莫單抗
141483-72-9
Thalidomide-5-O-CH2-COO(t-Bu)
ACETIC ACID, 2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-5-YL]OXY]-, 1,1-DIME
2682112-10-1
VH032-NH-CO-CH2-NHBoc
VH032-BOC-氨基
2010986-19-1
Arcitumomab
阿西莫單抗
154361-48-5
PBB No. 53
2,2,5,6-四溴聯(lián)苯
60044-25-9
Narnatumab
Narnatumab
1188275-92-4
Coltuximab
Coltuximab Ravtansine
1269764-99-9
Ontamalimab
Ontamalimab
2098790-40-8
Cibisatamab
賽必妥單抗
2101242-53-7
VH032-NH-CO-CH2-Br
2379404-33-6
Sudan Black B Impurity 1
蘇旦黑B雜質(zhì)1
65322-64-7
Thalidomide-NH-(CH2)3-NH-Boc
沙利度胺-NH-C3-NH-BOC
2093386-36-6
Biciromab
Biciromab
138783-13-8
6-Nitrobenz[a]pyrene
6-硝基苯并(A)芘
63041-90-7
Romosozumab
ROMOSOZUMAB
909395-70-6
Tacatuzumab
Yttrium (90Y) Tacatuzumab Tetraxetan
476413-07-7
Actoxumab
Actoxumab
1245634-25-6
Refanezumab
Refanezumab
1233953-61-1
Cusatuzumab
古妥珠單抗
1399546-01-0
Tabituximab
Tabituximab
1644134-10-0
Glucuronic Acid
葡糖醛酸
576-37-4
caffeic acid glucoside
咖啡酰葡萄糖苷
892501-29-0
Satumomab
沙妥莫單抗
144058-40-2
JYS002
1448189-66-9
JYS008
VH032-甲基-BOC
2827750-24-1
JYS004
VH032-BOC-丁胺
2412055-00-4
Ertumaxomab
ertumaxomab
509077-99-0
Mapatumumab
Mapatumumab
658052-09-6
Besilesomab
Besilesomab
537694-98-7
PBB No. 26
2,3',5-三溴聯(lián)苯
59080-35-2
Alacizumab
培戈-阿拉賽珠單抗
934216-54-3
Domagrozumab
Domagrozumab
1629605-31-7
Apamistamab
Iodine (131I) Apamistamab
2097132-02-8
Sirtratumab
Sirtratumab
1824663-82-2
Thalidomide-5-NH-CH2-COO(t-Bu)
THALIDOMIDE-5-NH-CH2-COO(T-BU)
2412056-28-9
JYS001
2111829-84-4
PBB-No. 49
2,2',4,5'-四溴聯(lián)苯
60044-24-8
2,2',5-Tribromobiphenyl
2,2,5-三溴聯(lián)苯
59080-34-1
Otlertuzumab
Otlertuzumab
1372645-37-8
Pateclizumab
帕替組單抗
1202526-59-7
Evinacumab
Evinacumab
1446419-85-7
4-Cyano-4'-undecylbiphenyl
4-氰基-4'-十一烷基聯(lián)苯
65860-74-4
Lintuzumab
Lintuzumab
166089-32-3
Nacolomab Tafenatox
Nacolomabtafenatox
150631-27-9
Thalidomide-4-NH-PEG1-COO(t-Bu)
PROPANOIC ACID, 3-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]ETHO
2140807-19-6
Naptumomab Estafenatox
埃托-那普妥莫單抗
676258-98-3
PCB No. 50
2,2',4,6-四氯聯(lián)苯
62796-65-0
Dinutuximab
dinutuximab
1363687-32-4
Radretumab
RADRETUMAB ( 雷曲妥單抗 )
1253180-81-2
Ifabotuzumab
IFABOTUZUMAB
1234137-51-9
Samrotamab
Samrotamab
2052591-32-7
Tamrintamab
TAMRINTAMAB (他林妥單抗 )
2148325-59-9
Thalidomide-4-NH-PEG2-COO(t-Bu)
PROPANOIC ACID, 3-[2-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]E
2140807-16-3
Thalidomide-4-NH-PEG3-NH-Boc
(2-(2-(2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚-4-基)氨基)乙氧基)乙氧基)乙氧基)乙基叔丁基)氨基甲酸酯
2204246-03-5
4'-Cyano-4-nonyloxybiphenyl
9OCB
58932-13-1
JYS009
VH032-丙基-BOC
2827750-25-2
Tositumomab
bexxar
208921-02-2
Carbophenothion-methyl-sulfone
甲基三硫磷砜, 10ΜG /ΜL于環(huán)己烷
62059-34-1
1,2-Dichlorobutane
1,2-二氯丁烷
616-21-6
Oregovomab
OregovoMab
213327-37-8
Testosterone-d4
[2H4] - 睪酮
638163-36-7
HuCC49
823788-82-5
Perakizumab
培拉凱珠單抗
1331830-76-2
Clivatuzumab
Clivatuzumab Tetraxetan
1462876-11-4
Thalidomide-4-O-CH2-COO(t-Bu)
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氧基)乙酸叔丁酯
1950635-36-5
112
113
114
115
116
117
118
119
120
Copyright 2007? ChemicalBook. All rights reserved.